Pirates pitcher Jameson Taillon has surgery for suspected testicular cancer

Pittsburgh Pirates pitcher Jameson Taillon underwent surgery Monday morning  at Allegheny General Hospital for suspected testicular cancer, the team announced.

Taillon attended The Woodlands High School. 

"Today I lost a piece of my 'manhood,'" Taillon said in a statement posted to his Twitter account . "But today I'm feeling like more of a man than I ever have. My journey hasn't been the smoothest. But it is my journey and I wouldn't change it for anything."

The treatment program won't be known until further tests are performed.

“Jameson has again proven to us what a strong person he is by the way in which he has reacted to this development. We are appreciative of Dr. Lyne and the staff at Allegheny General Hospital for their invaluable expertise and efforts in caring for Jameson,” Pirates GM Neal Huntington said in a statement.

“We have told Jameson that our only priority is his health and well-being. His teammates, our coaches, baseball staff and entire organization will support him in his recovery in every possible way and we will keep him in our thoughts and prayers.”

Taillon, 26, said he suffered groin discomfort earlier this week and was placed on the 10-day disabled list.

Taillon, the No. 2 pick behind Bryce Harper in the 2010 draft, had emerged as a reliable starter after a midseason callup in 2016 when he went 5-4 with a 3.38 ERA in 104 innings. After six starts in 2017, he was 2-1 with a 3.31 ERA.

This is just another setback he's faced during his career. In 2014, he underwent Tommy John surgery in 2014 and had surgery to address a sports hernia in 2015.

Taillon's surgery is similar to the one Colorado Rockies pitcher Chad Bettis faced in December. Unfortunately for Bettis, the cancer returned and he underwent chemotherapy. He is expected to miss most or all of the current season.

Contributing: AP

 

 

© 2017 USA TODAY


JOIN THE CONVERSATION

To find out more about Facebook commenting please read the
Conversation Guidelines and FAQs

Leave a Comment